Literature DB >> 32286766

Novel 2019 coronavirus SARS-CoV-2 (COVID-19): an overview for emergency clinicians.

A L Giwa1, Akash Desai2, Andrea Duca3.   

Abstract

The novel coronavirus, SARS-CoV-2, and its infection, COVID-19, has quickly become a worldwide threat to health, travel, and commerce. It is essential for emergency clinicians to learn as much as possible about this pandemic to manage the unprecedented burdens on healthcare providers and hospital systems. This review analyzes information from worldwide research and experience on the epidemiology, prevention, and treatment of COVID-19, and offers links to the most reliable and trustworthy resources to help equip healthcare professionals in managing this public health challenge. As the pandemic sweeps the United States, lessons learned from early centers of infection, notably New York and Northern Italy, can help localities to prepare.

Entities:  

Mesh:

Year:  2020        PMID: 32286766

Source DB:  PubMed          Journal:  Pediatr Emerg Med Pract        ISSN: 1549-9650


  11 in total

1.  From the Triage to the Intermediate Area: A Simple and Fast Model for COVID-19 in the Emergency Department.

Authors:  Erika Poggiali; Enrico Fabrizi; Davide Bastoni; Teresa Iannicelli; Claudia Galluzzo; Chiara Canini; Maria Grazia Cillis; Davide Giulio Ponzi; Andrea Magnacavallo; Andrea Vercelli
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

2.  Neurological problems in the context of COVID-19 infection in Egypt. A multicenter retrospective analysis.

Authors:  Mohammed A Azab; Ahmed Y Azzam; Ahmed E Salem; Ahmed Reda; Sherif F Hassanein; Mohamed Sabra; Islam S Gadelmoula
Journal:  Interdiscip Neurosurg       Date:  2021-08-17

3.  Protected code blue: using in situ simulation to develop a protected code blue and modify staff training protocol-experience in a large community teaching hospital during the COVID-19 pandemic.

Authors:  Fady A Youssef; Monique Patel; Hyunsoon Park; Jay V Patel; James Leo; Maged A Tanios
Journal:  BMJ Open Qual       Date:  2021-02

4.  Adaptation of a respiratory service to provide CPAP for patients with COVID-19 pneumonia, outside of a critical care setting, in a district general hospital.

Authors:  James Talbot-Ponsonby; Alvin Shrestha; Anitha Vijayasingam; Stuart Breck; Reza Motazed; Yogini Raste
Journal:  Future Healthc J       Date:  2021-07

5.  CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.

Authors:  Abdul Ashish; Alison Unsworth; Jane Martindale; Ram Sundar; Kanishka Kavuri; Luigi Sedda; Martin Farrier
Journal:  BMJ Open Respir Res       Date:  2020-11

Review 6.  Impact of COVID-19 on neurosurgical service: A one-year experience from a provincial countryside hospital in a rural area in north Egypt.

Authors:  Mohammed A Azab; Ahmed Y Azzam; Ahmed E Salem
Journal:  Interdiscip Neurosurg       Date:  2021-10-28

7.  Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers.

Authors:  Sylwia Kałucka; Ewa Kusideł; Agnieszka Głowacka; Paulina Oczoś; Izabela Grzegorczyk-Karolak
Journal:  Vaccines (Basel)       Date:  2022-03-06

8.  Strategies to Offer Uninterrupted Neurosurgical Care at a Tertiary Center in Makka amid COVID-19 Pandemic.

Authors:  Mohammed A Azab
Journal:  Asian J Neurosurg       Date:  2021-05-28

Review 9.  Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Omalla A Olwenyi; Shetty Ravi Dyavar; Arpan Acharya; Anthony T Podany; Courtney V Fletcher; Caroline L Ng; St Patrick Reid; Siddappa N Byrareddy
Journal:  J Mol Med (Berl)       Date:  2020-08-18       Impact factor: 5.606

10.  Adapted Diving Mask (ADM) device as respiratory support with oxygen output during COVID-19 pandemic.

Authors:  C Bibiano-Guillen; B Arias-Arcos; C Collado-Escudero; M Mir-Montero; F Corella-Montoya; J Torres-Macho; M J Buendía-Garcia; R Larrainzar-Garijo
Journal:  Am J Emerg Med       Date:  2020-10-28       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.